You are here: Home / Clinical Imaging / Application of Extracellular Gadolinium-based MRI Contrast Agents and the Risk of Nephrogenic Systemic Fibrosis

Application of Extracellular Gadolinium-based MRI Contrast Agents and the Risk of Nephrogenic Systemic Fibrosis

Val M. Runge, MD
Authors:
Val M. Runge, MD

Presented is a review of nephrogenic systemic fibrosis and how this influences daily practice (in contrast enhanced magnetic resonance imaging), with specific clinical recommendations.

Download PPTX-zip

Filed Under: Clinical Imaging, Clinical Methods & Techniques, Clinical Updates, Contrast Media Updates, Software & Hardware Updates
Tagged With: , , , ,